GZ/SAR402671
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GZ/SAR402671, covering 2019-12-09 to 2019-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease [Phase 2]